Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacological management of adverse events during treatment of chronic viral hepatitis in three Ivorian university hospitals .

International journal of clinical pharmacology and therapeutics - 1 May 2020

N'guessan-Irié Amenan Geneviève, Allah-Kouadio Emile, Gnépéhi Oko Bienvenu, Kohi Driga Steven, Allouka Kogbahonon Christiane Ella, Siransy-Kouakou N'doua Gisèle

Abstract excerpt

OBJECTIVE: This work aims to evaluate the therapeutic survey of adverse events during antiviral treatment of hepatitis in the three major University Hospitals in Abidjan. MATERIALS AND METHODS: A retrospective cross-sectional descriptive study of 203 patients from August 1, 2015, to July 31, 2018, enumerated adverse events during antiviral treatments, drugs used for their management, and their clinical or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carbamates
Share to Cote d'Ivoire

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hospitals, University

Share to Imidazoles

Share to Polyethylene Glycols

Share to Pyrrolidines

Share to Sofosbuvir

Share to Valine

Source

Identifiers

PMID: 32101521
DOI: 10.5414/CP203643

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacological management of adverse events during treatment of chronic viral hepatitis in three Ivorian university hospitals .PMID 32101521Read ↗

Study of Adverse Drug Effects of Direct-Acting Antivirals for Chronic HCV Infection at Fayoum Governorate, Egypt - A Pharmacovigilance Study.Semantic proximity Read ↗

Prevalence of drug-drug interactions with pangenotypic direct-acting antivirals for hepatitis C and real-world care management in the United States: a retrospective observational study.Semantic proximity Read ↗

Management and outcomes of side effects with focus on anaemia in patients with hepatitis C genotype 1 infection: the telaprevir early access program in patients from RomaniaSemantic proximity Read ↗

Effectiveness of alpha interferon (+ ribavirin) in the treatment of chronic viral hepatitis C genotypes 2 and 3 in a Brazilian sample.Semantic proximity Read ↗

Comparative safety and efficacy of conventional interferon versus pegylated-interferon based therapy for HCV: A retrospective cohort study from Gujranwala, Pakistan.Semantic proximity Read ↗

The adverse effects of interferon-free regimens in 149 816 chronic hepatitis C treated Egyptian patients.Semantic proximity Read ↗

EASL recommendations on treatment of hepatitis C 2014.Semantic proximity Read ↗

Safety aspects of protease inhibitors for chronic hepatitis C: adverse events and drug-to-drug interactions.Semantic proximity Read ↗

Comparative Real Life Egyptian Experience of the Combination of Sofosbuvir Plus Daclatasvir or Simeprevir for 12 Weeks in Naïve Cirrhotic Patients Infected with HCV Genotype 4.Semantic proximity Read ↗

EASL Recommendations on Treatment of Hepatitis C 2016.Semantic proximity Read ↗

[Treatment choice of the antiviral agent for the hepatitis C].Semantic proximity Read ↗

[Drugs for hepatitis B and C infection].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.